首页> 美国卫生研究院文献>International Journal of Molecular Sciences >Tumor-Associated CSF MicroRNAs for the Prediction and Evaluation of CNS Malignancies
【2h】

Tumor-Associated CSF MicroRNAs for the Prediction and Evaluation of CNS Malignancies

机译:肿瘤相关的CSF微小RNA用于中枢神经系统恶性肿瘤的预测和评估

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Cerebrospinal fluid (CSF) is a readily reachable body fluid that is reflective of the underlying pathological state of the central nervous system (CNS). Hence it has been targeted for biomarker discovery for a variety of neurological disorders. CSF is also the major route for seeding metastases of CNS malignancies and its analysis could be informative for diagnosis and risk stratification of brain cancers. Recently, modern high-throughput, microRNAs (miRNAs) measuring technology has enabled sensitive detection of distinct miRNAs that are bio-chemicallystable in the CSF and can distinguish between different types of CNS cancers. Owing to the fact that a CSF specimen can be obtained with relative ease, analysis of CSF miRNAs could be a promising contribution to clinical practice. In this review, we examine the current scientific knowledge on tumor associated CSF miRNAs that could guide diagnosis of different brain cancer types, or could be helpful in predicting disease progression and therapy response. Finally, we highlight their potential applications clinically as biomarkers and discuss limitations.
机译:脑脊液(CSF)是一种易于获取的体液,反映了中枢神经系统(CNS)的潜在病理状态。因此,它已成为发现多种神经系统疾病的生物标志物的目标。脑脊液也是中枢神经系统恶性肿瘤播种转移的主要途径,其分析可为脑癌的诊断和风险分层提供信息。近来,现代的高通量微RNA(miRNA)测量技术已使灵敏检测脑脊液中生物化学稳定的不同miRNA成为可能,并且可以区分不同类型的CNS癌症。由于可以相对容易地获得CSF标本,因此对CSF miRNA的分析可能对临床实践有希望的贡献。在这篇综述中,我们检查了有关肿瘤相关脑脊液miRNA的当前科学知识,这些知识可以指导不同类型脑癌的诊断,或者有助于预测疾病的进展和治疗反应。最后,我们重点介绍了它们作为生物标志物在临床上的潜在应用,并讨论了局限性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号